Actualidad
CNN CHILE · TERAPIA NEURAL (VIDEO)
DISAUTONOMIA en pacientes post-COVID y Terapia Neural (VIDEO)
Local anesthetics as a therapeutic tool for post COVID-19 patients A case report
Bases Científicas de la Terapia Neural: Therapeutic Use of Low-Dose Local Anesthetics in Pain, Inflammation, and Other Clinical Conditions: Scoping…
Diplomatura Univ en Terapia Neural Veterinaria 2024
CURSO NERVISMO RUSO - Bogotá Mayo 2024 (Presencial y Virtual)
Formación en Odontología Sistémica - 2024
USA Seattle APR 2024 - North American Academy of NT Conference
Newsletters
Stellate ganglion block reduces symptoms of Long COVID: A case series
- Detalles
- Escrito por David Vinyes
Abstract
After recovering from COVID-19, a significant proportion of symptomatic and asymptomatic individuals develop Long COVID. Fatigue, orthostatic intolerance, brain fog, anosmia, and ageusia/dysgeusia in Long COVID resemble “sickness behavior,” the autonomic nervous system response to pro-inflammatory cytokines (Dantzer et al., 2008). Aberrant network adaptation to sympathetic/parasympathetic imbalance is expected to produce long-standing dysautonomia. Cervical sympathetic chain activity can be blocked with local anesthetic, allowing the regional autonomic nervous system to “reboot.” In this case series, we successfully treated two Long COVID patients using stellate ganglion block, implicating dysautonomia in the pathophysiology of Long COVID and suggesting a novel treatment.
Key Words: Long COVID/PASC Myalgic encephalitis/chronic fatigue syndrome (ME/CFS) Postural orthostatic tachycardia syndrome (POTS) Dysautonomia Stellate ganglion block Cerebral blood flow
VER ARTICULO COMPLETO (FREE PDF)